Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Liminatus Pharma, Inc. - Class A Common Stock (NQ:LIMN)

0.1422 -0.0090 (-5.95%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,801,482
Open 0.1512
Bid (Size) 0.1400 (800)
Ask (Size) 0.1475 (1,200)
Prev. Close 0.1512
Today's Range 0.1359 - 0.1548
52wk Range 0.1320 - 33.66
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which stocks are moving on Wednesday? ↗
Via Chartmill
Here are the top movers in Wednesday's session. ↗
Via Chartmill

Performance

YTD
-77.8%
-77.8%
1 Month
-30.6%
-30.6%
3 Month
-38.8%
-38.8%
6 Month
-83.1%
-83.1%
1 Year
-99.4%
-99.4%

More News

Read More
Which stocks are gapping on Wednesday? ↗
Via Chartmill
News headline image
Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds
From Liminatus Pharma Inc.
Via GlobeNewswire
Which stocks are experiencing notable movement on Friday? ↗
Via Chartmill
Unusual volume stocks in Friday's session ↗
Via Chartmill
Keep an eye on the top gainers and losers in Friday's session. ↗
Via Chartmill
Friday's session: gap up and gap down stocks ↗
Via Chartmill
Discover the top movers in Friday's pre-market session. ↗
Via Chartmill
News headline image
Liminatus Pharma Announces Nasdaq Delisting Notification
From Liminatus Pharma Inc.
Via GlobeNewswire
Most active stocks in Thursday's session ↗
Via Chartmill
Here are the top movers in Thursday's session. ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
Liminatus Pharma Announces Proposed Merger with InnocsAI to Expand Oncology Cell Therapy Pipeline
From Liminatus Pharma Inc.
Via GlobeNewswire
News headline image
Which stocks are most active on Wednesday? ↗
Via Chartmill
Topics Artificial Intelligence
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody
From Liminatus Pharma Inc.
Via GlobeNewswire
Top movers analysis one hour before the close of the markets on 2026-02-17: top gainers and losers in today's session. ↗
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
Tuesday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering
From Liminatus Pharma, Inc.
Via GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Which stocks are experiencing notable movement on Wednesday? ↗
Via Chartmill
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill

Frequently Asked Questions

Is Liminatus Pharma, Inc. - Class A Common Stock publicly traded?
Yes, Liminatus Pharma, Inc. - Class A Common Stock is publicly traded.
What exchange does Liminatus Pharma, Inc. - Class A Common Stock trade on?
Liminatus Pharma, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Liminatus Pharma, Inc. - Class A Common Stock?
The ticker symbol for Liminatus Pharma, Inc. - Class A Common Stock is LIMN on the Nasdaq Stock Market
What is the current price of Liminatus Pharma, Inc. - Class A Common Stock?
The current price of Liminatus Pharma, Inc. - Class A Common Stock is 0.1422
When was Liminatus Pharma, Inc. - Class A Common Stock last traded?
The last trade of Liminatus Pharma, Inc. - Class A Common Stock was at 06/05/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.